Ni Kang Therapeutics, Inc. reported raising $200 Million in an initial SEC Form D filing, from an offering of $200 Million
Amount Raised
$200 Million
Round Type
Venture
WilmingtonBiotechnologyBiotechnology ResearchQuick answer
NiKang Therapeutics raised $200 Million in a funding round, dated June 7, 2021. NiKang Therapeutics is based in Wilmington, Delaware, United States.
- How much did NiKang Therapeutics raise?
- NiKang Therapeutics raised $200 Million in a funding round on June 7, 2021.
- What does NiKang Therapeutics do?
- NiKang Therapeutics, Inc. is a privately-held biotech company focused on developing novel small molecule oncology drug discovery.
- Where is NiKang Therapeutics based and how big is it?
- NiKang Therapeutics is based in Wilmington, Delaware, United States.
- Who are the decision-makers at NiKang Therapeutics?
- Fundz holds 1 contact at NiKang Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology Research and Biotechnology around the same time
Companies in the same sectors as NiKang Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Gross-Wen Technologies raised $2.5M on July 22, 2021.
- Arzeda raised $26M on July 22, 2021.
- Anocca raised $47M (Series B) on July 22, 2021.
- Phytoform raised $5.5M on July 22, 2021.
- Kandu Health™ raised $260M on July 22, 2021.
- Akari Therapeutics raised $12M on July 22, 2021.
Who to call at NiKang Therapeutics, and when
A new round usually means NiKang Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day NiKang Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at NiKang Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at NiKang Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment NiKang Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
NiKang Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.